• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Michael Stein
Michael Stein
Michael Stein

Michael Stein

Partner

  • Frankfurt Germany
Contact Me Today
+49 69 97130 0
vCard
Email me Call me
Featured award

JUVE 2025/2026

Frequently recommended lawyer for Private Equity, especially in the healthcare sector

Scroll to featured award

Michael's clients are primarily financial investors and their portfolio companies as well as strategic investors from Germany and abroad. His practice includes the structuring, negotiation and implementation of complex corporate transactions (buy-side and sell-side, cross-border and domestic), including leveraged buyouts. He has particular expertise in advising on transactions in the highly regulated healthcare sector. Michael is described by his clients as “solution-oriented and pragmatic”. Clients also praise his extensive knowledge of the healthcare sector. He has published a number of articles on corporate law topics in professional journals and regularly lectures on private equity topics. He is co-author of the handbook on medical and healthcare law (Beck'sches Formularbuch Medizin- und Gesundheitsrecht).

Michael Stein is co-head of the German Private Equity practice.

Expertise

Services and Groups

Corporate/M&A & capital markets
Private equity
General corporate
Joint ventures

Sectors

Life sciences & healthcare
Health & social care and investors
Medical devices
Pharmaceuticals

CV

Since 2010 Partner, Taylor Wessing
2001 – 2010 Associate/Counsel, Corporate M&A/Private Equity, Hogan Lovells, Frankfurt am Main and London
2001 Admitted and established as a lawyer, Frankfurt am Main
2000 Second state examination, Koblenz
1998 First state examination, Trier
1993 – 1998 Law studies, Trier and Seville

Career

Since 2010 Partner, Taylor Wessing
2001 – 2010 Associate/Counsel, Corporate M&A/Private Equity, Hogan Lovells, Frankfurt am Main and London

Education

2001 Admitted and established as a lawyer, Frankfurt am Main
2000 Second state examination, Koblenz
1998 First state examination, Trier
1993 – 1998 Law studies, Trier and Seville

Publications

Steigende Haftungsrisiken für Klinikgeschäftsführung - So stellen Sie rechtzeitig die entscheidenden juristischen Weichen, in: Klinik Management aktuell, Sonderdruck 09/2020, 25. Jg., S. 46-49, gemeinsam mit Christopher Peine

Herausforderungen für M&A-Projekte durch die Corona-Krise: Auswirkungen auf Kaufpreis, Kaufpreisfindung und -sicherung, in: M&A Review, 06/2020, gemeinsam mit Christopher Peine

Der M&A- und Private-Equity-Markt im Life Sciences und Healthcare-Sektor, in: Health&Care Management, 04/2020, gemeinsam mit Christopher Peine

Transaktionen – Veräußerung und Erwerb von Krankenhäusern, Rehabilitations- und Pflegeeinrichtungen (Kapitel J.), in: Scholz/Treptow, Beck’sches Formularbuch Medizin- und Gesundheitsrecht, 1. Auflage 2017, gemeinsam mit Christopher Peine

Die Suche nach dem richtigen Partner – Strukturfragen der Gesundheitsholding, in: HCM Kolumne, 03/2017, gemeinsam mit Christopher Peine

Finanzinvestoren im Gesundheitsmarkt – Transaktionen und Kooperationen als Bestandteil der Investitionsstrategie, in: HCM Kolumne, 01/2017, gemeinsam mit Christopher Peine

Die Verbundlösung - eine Bestandsaufnahme aus rechtlicher Sicht, in: HCM Kolumne, 11/2015 und HCM Ausgabe 1-2/2016, 7. Jg., S. 53, gemeinsam mit Christopher Peine

Unternehmensverkäufe: Exklusiv-Vereinbarungen versus Auktion, in: FYB Financial Yearbook, 12/2014

Kostendruck, knappe Kassen und die Konsolidierung des Marktes Rosige Zeiten für Privatinvestoren im Gesundheitswesen, in: NZS 2011, 525 ff., gemeinsam mit Oliver Klöck

Anmerkung zu BGH-Urteil vom 11.12.2006 – II ZR 243/05, Haftung eines fakultativen Aufsichtsrats einer GmbH, DZWiR 2007, 327 ff.

Anmerkung zu BGH-Urteil vom 16.01.2006 – II ZR 76/04, Kapitalaufbringung bei der GmbH im Rahmen eines sog. Cash-Pool-Systems, DZWiR 2006, 248 ff.

Kapitalerhaltung bei GmbH und AG, DZWiR 2004, 493 ff.

Additional languages

English Hungarian Spanish

Awards

JUVE 2025/2026

Featured

Frequently recommended lawyer for Private Equity, especially in the healthcare sector

Legal 500 2025

Recommended Lawyer for Private Equity

The Best Lawyers™ in Germany 2025

Best lawyers: Private equity

Legal 500 2025

Recommended lawyer for Healthcare and life sciences

Frequently recommended lawyer for M&A

Frequently recommended lawyer for Private Equity, especially health care

Leading individual: Private Equity Law

Recommended lawyer: Healthcare and life sciences

Key lawyer for M&A

Frequently recommended lawyer for M&A

Frequently recommended lawyer for Private Equity, especially health care

"fair and solution-oriented", competitor

Leading individual: Private Equity Law

Recommended lawyer: Healthcare

Excellent lawyer: Healthcare, pharmaceuticals & biotech

Leading individual: Private Equity

Experience

Comprehensive advice to International Chemical Investors Group (ICIG) on M&A transactions

Advising ICIG on various national and international M&A transactions, including the acquisition of Evonik's site in Lülsdorf, near Cologne, and operations in Wesseling.

Press release
Stephan Doom, Solicitor (England & Wales)|LL.M. (Nottingham)
Michael Stein
Hannes Tutt
Dr. Anja Fenge, LL.M.
Dr. Michael Kieffer
Dr. Stefan Horn, LL.B.

NORD Holding and Zentrum Gesundheit on the acquisition of REALEYES Group

The NORD Holding portfolio company Zentrum Gesundheit, the leading ophthalmology group in Lower Saxony, has acquired the majority in REALEYES Group. REALEYES is a market-leading premium provider in the field of ophthalmology in the greater Munich area with over 100 employees at a total of 21 locations. REALEYES offers a wide range of medical treatments in addition to a growing refractive range.

Press release
Michael Stein
Christopher Peine

Nordmed Healthcare GmbH (Medicover Gruppe) on the acquisition of AWO Krankenhaus Calbe

Advised Nordmed Healthcare GmbH (Medicover Group) on the acquisition of AWO Krankenhaus Calbe, a hospital for internal medicine with a geriatric focus. Medicover Group provides integrated and high-quality healthcare services.

Press release
Michael Stein
Christopher Peine

NORD Holding on the acquisition of Zentrum Gesundheit Gruppe

Advised NORD Holding Unternehmensbeteiligungsgesellschaft mbH on the acquisition of a majority interest in Zentrum Gesundheit Group from Waterland Private Equity Investments. Zentrum Gesundheit is a leading German group of eye surgery and diagnostic centers.

Michael Stein
Christopher Peine

Oberberg GmbH on acquisition of Panorama Fachkliniken

Advised Oberberg GmbH on the acquisition of Panorama Fachkliniken (Scheidegg/Allgäu).) As a result of the acquisition, the Berlin-based company's nationwide network will in future be made up of thirteen facilities, making it the leading quality association of private clinics in the field of psychiatry, psychotherapy and psychosomatics in the German-speaking countries.

Press release
Michael Stein
Christopher Peine

The Cadmus Group LLC on the acquisition of ifok and Meister Consultants Group

Advised The Cadmus Group LLC, a leading US strategy consultancy on the acquisition of the consulting companies ifok GmbH and Meister Consultants Group.

Michael Stein
Christopher Peine

Michael's news & insights

View Michael's insights
Suspension bridge vanishing point
Click here to find out more
Corporate/M&A & capital markets

Advising Azenta on its US$63 million sale of B Medical Systems

13 January 2026

by William Belcher and Michael Stein

Glass.Mapper.Sc.Fields.Image?.Alt
Private equity

Audit and Tax Advisory Firms – the New Healthcare Platforms?

26 May 2025

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Taylor Wessing advises International Chemical Investors Group on acquisition of Evonik's Lülsdorf chemical site

ICIG has been advised on the deal by a team led by M&A partners Stephan Doom and Michael Stein

14 April 2023

by multiple authors

Click here to find out more
View Michael's insights

Related news & insights

Hand writing on post-it notes
Corporate/M&A & capital markets

Taylor Wessing advises Hypax on the carve-out acquisition of the WOLF-Garten business from Stanley Black & Decker

28 January 2026

by multiple authors

Click here to find out more
Hand Holding Blue Paper Airplane on green background
Careers

Oli Denne recognised in The Lawyer's Hot 100 2026

28 January 2026

by Oli Denne and Shane Gleghorn

Click here to find out more
Patterned pills
Life sciences & healthcare

Life Sciences Made in Europe – The European Commission’s Life Sciences Strategy 2030

27 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Up Arrow
Corporate/M&A & capital markets

Advising Toho Global on its acquisition of Anime Limited

27 January 2026

by multiple authors

Click here to find out more
Overhead view of scientist using centrifuge machine
Life sciences & healthcare

Research and innovation as a competitive advantage – Legal framework for Life Sciences made in Europe

27 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Blood samples
Life sciences & healthcare

Adoption of Commission Implementing Regulation (EU) 2025/2086: New Rules on the Joint Clinical Assessment of Medical Devices and In Vitro Diagnostic Medical Devices

23 January 2026
Briefing

by Irina Rebin and Daniel Dietrich

Click here to find out more
Low Angle View Of Flags Waving
Logistics & transport

EU Inc.: Founders and companies with expansion plans must now think strategically

23 January 2026
Quick read

by Dr. Benedikt Groh and Fritz Krings

Click here to find out more
Office facade reflection
Life sciences & healthcare

Advising Nuclera on its extended Series C funding to US$87 million

22 January 2026

by Ross McNaughton and Oli Denne

Click here to find out more
Windows of modern futuristic glass
Life sciences & healthcare

Word on the street at the J.P. Morgan Healthcare Conference 2026: Part one

21 January 2026
In-depth analysis

by multiple authors

Click here to find out more
Low angle view of futuristic skyscrapers
Life sciences & healthcare

Word on the street at the J.P. Morgan Healthcare Conference 2026: Part two

21 January 2026
In-depth analysis

by multiple authors

Click here to find out more
View all insights

Related people

Germany
Global
Joana Pamukova

Joana Pamukova

Senior Associate

Frankfurt
+49 69 97130 0
Email me
View profile
Peter Hellich

Dr. Peter Hellich

Partner

Munich
+49 89 21038 0
Email me
View profile
Dr. Oliver Rothley

Dr. Oliver Rothley

Partner

Munich
+49 89 21038 283
Email me
View profile

Dr. Daniel Werner (geb. Jarzembowski)

Salary Partner

Hamburg
+49 40 36803 0
Email me
View profile

Ercan Cömert

Senior Associate

Frankfurt
+49 69 97130 0
Email me
View profile
Anne Kathrin Hoppe

Anne-Kathrin Hoppe

Salary Partner

Hamburg
+49 40 36803 0
Email me
View profile
Leonard Raphael

Leonard Raphael, LL.M. (Krakau)

Senior Associate

Duesseldorf
+49 211 8387 0
Email me
View profile
Hassan Sohbi

Hassan Sohbi

Associated Partner

Frankfurt
+49 69 97130 0
Email me
View profile
Kathleen Munstermann

Kathleen Munstermann-Senff, LL.M. (Medical Law)

Salary Partner

Hamburg
+49 40 36803 0
Email me
View profile
Ingo Vinck

Ingo Vinck

Senior Associate

Duesseldorf
+49 211 8387 0
Email me
View profile
Full team
Claudia Steegmüller

Claudia Steegmüller

Partner

Vienna
+43 1 71 65 50
Email me
View profile

Christoph Hezel

Partner

Shanghai
+86 21 6247 7247
Email me
View profile
Dr. Philip Cavaillès, Rechtsanwalt, Solicitor (England & Wales)

Dr. Philip Cavaillès

Partner

Munich
+49 172 64 28 499
Email me
View profile
Toon Rummens

Toon Rummens

Partner

Brussels
+ 32 485 965 663
Email me
View profile
Laurence Lapeyre

Laurence Lapeyre

Partner

Paris
+33 1 72 74 03 53
Email me
View profile
josef fuss

Josef Fuss

Partner

London
+44 20 7300 4110
Email me
View profile
Markta Crkov

Markéta Cvrčková

Partner

Prague
+420 224 81 92 16
Email me
View profile
Leonard Raphael

Leonard Raphael, LL.M. (Krakau)

Senior Associate

Duesseldorf
+49 211 8387 0
Email me
View profile

Edward Waldron

Partner

London
+44 (0)20 7300 4968
Email me
View profile
Lukas Beermann

Lukas Beermann

Associate

Duesseldorf
+49 211 8387 0
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing